Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

GnRH treatment can reduce breast cancer cell invasion.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Fat cells are important for tissue repair and stem cell support in various body parts.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The link between anabolic agents and colorectal cancer risk is unclear.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.